iiinova — where your digital self keeps evolving

Reposted by Armando Andres Roca Suarez

bioRxivpreprint @biorxivpreprint.bsky.social · 07/12/2025

Precision-cut liver slices as a model for the evaluation of host-targeting agents against hepatitis B and delta viruses www.biorxiv.org/content/10.64898/20…

011

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 18/09/2025

⏳ Only 2 weeks left to submit abstracts for #HEP-DART 2025! Deadline: September 29, 2025 Join leading researchers and clinicians in 🌎 Honolulu, Hawaii, and share your latest work in #hepatitis research, treatment, and global health. 👉 informedhorizonseducation.com/abstracts-he...

031

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · 13/09/2025

Thank you team! You did an amazing work at presenting your data and we had a lot of fun!!! #HBV2025 @anrs-mie.bsky.social @ihuhepatolyon.bsky.social

052

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · 08/09/2025

Backstage from the #HBV2025 international meeting. we’re getting ready to welcome you all in Berlin! @anrs-mie.bsky.social @ihuhepatolyon.bsky.social

022

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 02/09/2025

🎓 [OFFRE DE POST-DOC – 24 mois] 📍 Domaine : Santé publique / Épidémiologie 📅 Candidatures jusqu’au 17 octobre 2025 🎓 Profil recherché : - Doctorat en santé publique, épidémiologie ou discipline connexe - Solides compétences en analyse de données 👉 Plus d'informations dans la fiche de poste

011

Reposted by Armando Andres Roca Suarez

The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · 19/08/2025

FDA approves semaglutide for adults with metabolic-associated steatohepatitis with moderate-to-advanced fibrosis www.fda.gov/drugs/news-e... #LiverSky #MedSky

fda.gov

FDA Approves Treatment for Serious Liver Disease Known as ‘MASH’

Action Will Provide New Therapy for Growing Public Health Issue

033

Armando Andres Roca Suarez @andresroca.bsky.social · 31/07/2025

We look forward to receiving your contributions to the special issue "Cellular Immune Response to Hepatitis Viruses". Deadline : 31 January 2026 #Hepsky #Liversky #Medsky www.mdpi.com/journal/viru...

mdpi.com

021

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 28/07/2025

🌍 Today is #WorldHepatitisDay 2025! 〽️ At IHU Everest, we are committed to raising #awareness and support the global campaign: “Let’s break it down.” www.worldhepatitisday.org/take-action/ 🤝 Let’s unite around one powerful message: Take action. Get tested. End the stigma. #EndStigma #HealthForAll

021

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 12/06/2025

👟🎽🚲 16-22 juin : bougez pour le don d’organes ! 🫵 Rejoignez la course virtuelle STRAVA : marchez, courez ou pédalez. 🎯 Défi collectif : atteindre 6034 km, nombre de greffes réalisées en France en 2024. 📲 Infos via le QR code, rejoignez-nous vite ! #DéfiDon #DonDorganes #TeamHCL #Greffe #Solidarité🤝!

011

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · 11/06/2025

🚨 Register now for the 2025 International HBV Meeting! 📅Sept. 8-12, 2025 📍Berlin, Germany ➡️ Deadline for abstract submission June 16th. Early bird registration before July, 18th 🔗 Visit www.hbvmeeting.org for details @ihuhepatolyon.bsky.social @anrs-mie.bsky.social @easlnews.bsky.social

022

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 27/05/2025

🔬🧪 Two open calls at the IHU EVEREST to develop ambitious projects on virology, metabolism, oncology and more! 1) Junior Professor on bioinformatics 📆Deadline: June 30th 2025 2) Group Leader on chronic liver disease 📆Deadline: Sep 1st 2025 ihu-hepatolyon.fr/en/join-us #Liversky #Medsky #Hepsky

132

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 14/05/2025

🥁 DEADLINE EXTENDED: June 15! We are looking for: ✅ 2 research engineers motivated to work on HBV/HDV biology and antiviral treatments and on the development of innovative 3D ex-vivo cell culture models! www.ihu-hepatolyon.fr/en/join-us/ #HBV #research #virology #Hepsky #Medsky #Liversky

122

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 30/04/2025

📢 We are delighted to announce that Prof. John Tavis 🇺🇲 will be giving an in-person talk in Lyon 🇫🇷 🗓️ Tuesday, May 13, 2025 🕤 9:30 – 10:30 AM His invited talk, "HBV polymerase: Biochemical engineering and drug discovery", is an open event. We look forward to welcoming you! #HBV #hepatology #liver

011

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · 11/05/2025

The new EASL CPGs on HBV infection have been released yesterday at #EASLCongress What an effort, but what a great journey with an outstanding panel of colleagues! #HBV #Hepatology @ihuhepatolyon.bsky.social doi.org/10.1016/j.jh...

232

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 31/03/2025

🆕 🔬 🧪 Open call for a Junior Professor Position to develop an ambitious project in #liver #pathobiology on #bioinformatics & #biostatistics that will cover one or more of these topics: #virology, metabolism, #oncology, #immunology etc. 📆 Deadline: 1st June 2025 www.ihu-hepatolyon.fr/en/join-us/

122

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · 01/04/2025

🥁 A second call for application is open for MSCA-COFUND International Doctoral Programme ArchiFun. We have a project linking HBV splicing and liver pathogenesis. The deadline for application is May 31st 2025. ⬇️ More details here: lnkd.in/d459VH_B #HBV #liver #PhD @ihuhepatolyon.bsky.social

lnkd.in

This link will take you to a page that’s not on LinkedIn

022

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 22/04/2025

🔙 [ Looking back] on our annual #Hepatology and #Liver Transplantation Days! 📣 We were glad to welcome Catherine Postic as one of our guest speakers. During her impactful presentation, titled 👉 “Novel insights into glucose and MASLD”, she shared her most recent research. #MASLD #GlucoseMetabolism

011

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 16/04/2025

💡📅 As World Liver Day approaches on April 19, 2025, our teams are proud to stand alongside the 🌍 global community in raising awareness. 👉 Learn more about our initiatives to preserve, heal, and save livers on our website: www.ihu-hepatolyon.fr/en #WorldLiverDay #MedicalResearch #HealthAwareness

011

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 11/04/2025

🔝〽️2-day multidisciplinary event on #hepatology and #liver #transplantation! On April 8–9 2025 in Lyon, we had the pleasure of bringing together our community and a diverse audience to share the latest advances in basic, translational, and #clinical #research in hepatology within our IHU.

011

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 15/04/2025

🔙 on our Hepatology and Liver Transplantation Days! 🤝 We had the pleasure of welcoming @tz-hirsch.bsky.social for a presentation titled: Evolution of Hepatoblastoma: From #Liver Development to Chemoresistance. 🧫 His talk sparked dynamic discussions during the session on #hepatic #pathogenesis.

022

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · 21/03/2025

Great adventure for our #PaThLiv unit members at #GHS2025! Three oral presentations, a poster and always a strong engagement for open science and against viral hepatitis! @ihuhepatolyon.bsky.social #Liversky #HBV #standup4science

011

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · 21/03/2025

What’s your job? Is it hard? How do you become a researcher? What skills do you need to begin? Is the salary adequate? 😅 talking with high school students and presenting research and @ihuhepatolyon.bsky.social #womeninSTEM #standup4science

042

Reposted by Armando Andres Roca Suarez

Amandine Verga @amandineverga.bsky.social · 11/03/2025

Présentation sur les nouvelles approches pour guérir l’Hépatite B par Fabien Zoulim de @ihuhepatolyon.bsky.social

Fabien zoulim est sur scène pour faire sa présentation

143

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · 21/02/2025

Here we are! The lab family grows: come and join us! we are looking for - 1 post-doc - 2 research engineers - 1 cell culture technician More info here: www.ihu-hepatolyon.fr/en/join-us/ @ihuhepatolyon.bsky.social @inserm.fr @anrs-mie.bsky.social #HBV #hepatology #3Dmodels #virology #antivirals

033

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 20/02/2025

🥁 WE'RE HIRING! We are looking for: ✅ 1 Post-Doc fellow ✅ 2 research engineers ✅ 1 research technician motivated to work on HBV/HDV biology and antiviral treatments and on the development of innovative 3D ex-vivo cell culture models! www.ihu-hepatolyon.fr/en/join-us/ #HBV #research #virology

052

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 11/02/2025

📣 Happy to share some pictures from our last event on Hepatic organoids and and ex-vivo models, held on Monday 3rd February organized by Jennifer Rieusset at CarMeN Laboratory INRAE UMR1397-INSERM U1060. Thanks again to all the speakers and attendees. #organoids #Medsky #Hepsky #Liversky

021

Reposted by Armando Andres Roca Suarez

Itai Yanai @itaiyanai.bsky.social · 31/01/2025

Is it cheating to explore a dataset for things you did not specifically hypothesize when creating it? We discussed this today at the Postdoc Night Science NYC session. It’s not cheating! The point is make discoveries & then test them in day science. Use this night science trick!

2163

Reposted by Armando Andres Roca Suarez

Eric Topol @erictopol.bsky.social · 27/01/2025

Spatial multi-omics has just gone to the next level! www.nature.com/articles/s41... www.nature.com/articles/s41... —Integration of 5 omic modalities w/ spatial resolution at 20 -50 μm —"a new era for characterizing tissue & cellular heterogeneity that single-modality studies alone could not reveal"

215449

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 21/01/2025

IHU Everest is organising Symposium on liver organoids and 3D ex-vivo models. This event will be held - in person only - on February 3rd 2025, at CarMeN laboratory, on the Lyon-Sud hospital site. Registration is free but mandatory: www.ihu-hepatolyon.fr/en/organoids... #hepatology #organoids #IHU

ihu-hepatolyon.fr

Hepatic Organoïds Symposium - IHL - Institut d’Hépatologie de Lyon

Monday, February 3rd 2025 IHU Everest is organizing a Symposium on liver organoids and 3D ex-vivo models.This event will be held on Monday, February 3rd 2025, at CarMeN laboratory, on the Lyon-Sud hos...

032

Reposted by Armando Andres Roca Suarez

Science Magazine @science.org · 06/01/2025

"Scientists come in many forms and can serve society in different ways. It took me a long time to realize that, but I am at peace with it now." This week's #ScienceWorkingLife: scim.ag/3BWd1H2

An illustration of a person leading a group of people into a giant book, symbolizing a career in educational outreach. The text says: "As an early-career researcher, I loved doing outreach. So I made it my career"

0639

Reposted by Armando Andres Roca Suarez

NEJM.org @nejm.org · 04/01/2025

A 𝘁𝗼𝗹𝗹-𝗹𝗶𝗸𝗲 𝗿𝗲𝗰𝗲𝗽𝘁𝗼𝗿 is a receptor protein expressed by macrophages and other cells that detect and respond to pathogens. Read the full definition on the NEJM Illustrated Glossary: nej.md/4fD2u0Y #MedSky #ScienceSky

A receptor protein expressed by macrophages and other cells that detect and respond to pathogens. (Toll-like receptors are also known as pattern-recognition receptors.) Certain toll-like receptors (e.g., TLR7 and TLR8) can recognize molecules broadly shared by pathogens (the so-called pathogen-associated molecular patterns, or PAMPs) that are distinct from normal host molecules. Certain toll-like receptors (e.g., TLR7) play a role in the activation of autoreactive B cells and dendritic cells by self-antigens. Activation of toll-like receptors (which are expressed on innate immune cells and other cell types) by PAMPs initiates an immune response involving the production of type I interferons and other cytokines. Agonists of toll-like receptors are under investigation for the treatment of viral infections and cancer.

3376

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 29/12/2024

Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta. @jhepatology.bsky.social @fabienhepatolyon.bsky.social www.journal-of-hepatology.eu/article/S016... #HBV #Hepsky #Medsky #Liversky

011

Reposted by Armando Andres Roca Suarez

ImmunoSketch @actuallypublished.bsky.social · 22/12/2024

In newborns, tiny traffic cops in the liver need a GPS to find their way to the bloodstream and protect against infections. @brunaraujodavid @Kubes_Lab @immunoeditor.bsky.social @sciimmunology.bsky.social t.co/YU2WdkN4HF #ImmunoSky 🧪

032

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 23/12/2024

Hepatitis B virus DNA integration: Implications for diagnostics, therapy, and outcome. @jhepatology.bsky.social www.journal-of-hepatology.eu/article/S016... #HBV #Liversky #Hepsky #Medsky

021

Reposted by Armando Andres Roca Suarez

NEJM.org @nejm.org · 09/12/2024

🧵 Combination Therapy for Chronic HBV Infection (a thread) Chronic hepatitis B virus (HBV) affects more than 3% of the world population and is responsible for approximately 1.1 million deaths annually. Full article: nej.md/49nfu9F 1/15 #MedSky

23014

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 04/12/2024

🆕 The recording of the 2024 Bruce Witte Lecture is online: www.youtube.com/watch?v=0Hqc... More info on the Hepatitis B Foundation website 👉 www.hepb.org/news-and-eve... #hepatology #lecture

youtube.com

2024 Bruce Witte Lecture

YouTube video by Hepatitis B Foundation

031

Armando Andres Roca Suarez @andresroca.bsky.social · 03/12/2024

Big thanks to the members of the @ihuhepatolyon.bsky.social, IP-cure-B 🇪🇺 and Gut for the opportunity to share our work. Barbara Testoni, Fabien Zoulim, Marie-Laure Plissonnier. #HBV #Kupffer #Liver youtu.be/rhxBiquxHfU?...

youtu.be

TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV

YouTube video by Gastroenterology at BMJ

061

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 28/11/2024

📅 Falk Symposium 240: Experimental #Hepatology Days. April 24-26 in Lyon. The deadline for the poster submission is January 15, 2025. More information below. 👇

011

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 26/11/2024

🆕Dans le cadre du Festival de la Santé Mondiale, le 16 Décembre 2024, le Prof. Massimo Levrero présentera notre @ihuhepatolyon.bsky.social Everest. 👉 Plus d'informations sur le programme complet et inscription : t.co/x368CEv6G1

031